Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1992825 SAN FRANCISCO, CA
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$122
+$60 QoQ
Shares Held
111
+208.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 101 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,745,890 across 281 Biotechnology names. INO ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,922 $2,444,905
2 MRNA
Moderna, Inc.
 15,429 $1,080,492
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,088 $985,292
4 HALO
Halozyme Therapeutics, Inc.
 11,241 $879,833
5 EXEL
Exelixis, Inc.
 14,171 $771,044
6 REGN
Regeneron Pharmaceuticals, Inc.
 1,075 $670,305
7 VKTX
Viking Therapeutics, Inc.
 15,171 $591,820
8 BMRN
Biomarin Pharmaceutical Inc
 7,871 $450,378

All Filings in INO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $122 111
2026-03-31 $62 36
2025-12-31 $27 16
2025-09-30 $37 16
2025-06-30 $32 16
2025-03-31 $26 16
2024-12-31 $84 46
2024-09-30 $208 36
2024-06-30 $6,859 849
2024-03-31 $11,798 850
2023-12-31 $5,332 10,455
2023-09-30 $4,077 10,455
2023-06-30 $4,592 10,205
2023-03-31 $8,368 10,205
2022-12-31 $15,919 10,205